Earnings from Procter & Gamble, Tesla, Lockheed Martin

Earnings from Procter & Gamble, Tesla, Lockheed Martin

CNBC’s Jim Cramer on Friday told investors to gear up for a “fast and furious” slew of earnings reports next week that could lead to some profit-taking, including Procter & Gamble, Tesla and Lockheed Martin. This week brought solid gains for the major indexes — with the S&P 500 closing on Friday at an all-time … Read more

Renewed interest in ADCs will continue in 2024

Renewed interest in ADCs will continue in 2024

Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images SAN FRANCISCO — An established but promising group of cancer drugs was a red-hot market in 2023, and more companies could look to the treatments to fuel growth in the year ahead. … Read more

Jim Cramer compares NFL playoff teams to stock picks

Jim Cramer compares NFL playoff teams to stock picks

CNBC’s Jim Cramer on Friday compared all NFL 14 teams competing in the playoffs to some of his top stock picks. “As I was reviewing this weekend’s slate of six games and the 14 teams that made the playoffs, I realized many of them are reminiscent of my favorite companies,” he said. “Tonight, I want … Read more

J&J to acquire Ambrx Biopharma, a cancer drug developer, for $2B

J&J to acquire Ambrx Biopharma, a cancer drug developer, for B

An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Monday said it will pay $2 billion in cash to acquire Ambrx Biopharma, a drugmaker specializing in one of the hottest areas of cancer treatment. … Read more

Jim Cramer examines the Dow’s best and worst performers of 2023

Jim Cramer examines the Dow’s best and worst performers of 2023

CNBC’s Jim Cramer on Tuesday broke down the five best and worst performers on the Dow Jones Industrial Average during 2023. Cramer compared each Dow company’s closing price in 2022 to the end of 2023, noting the most significant winners and losers. Many tech-related stocks saw significant full-year gains, while some stocks with the greatest … Read more

Only 2 are in the Magnificent Seven

Only 2 are in the Magnificent Seven

It was a big rebound year for stocks. The S & P 500 gained 24%, while the Dow rose 14% and the tech-heavy Nasdaq rose more than 43%. All three major averages were coming off big losses in 2022. Our portfolio of 33 stocks also bounced back. Throughout the year, we held onto our conviction … Read more

Investor Michael Farr is back with his top 10 stocks he’s buying for 2024, and the tilt is defensive

Investor Michael Farr is back with his top 10 stocks he’s buying for 2024, and the tilt is defensive

Traders work on the floor of the New York Stock Exchange (NYSE) on the first day back since the Christmas holiday on December 26, 2023 in New York City.  Spencer Platt | Getty Images News | Getty Images In each of the past 16 Decembers I have selected and invested personally in 10 of the … Read more

Medicare drug price negotiations what’s ahead in 2024

Medicare drug price negotiations what’s ahead in 2024

Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker | Getty Images U.S. patients and drugmakers will get a first glimpse of how much Medicare can negotiate down drug prices in 2024, setting the … Read more

Biden administration asserts power to seize drug patents

Biden administration asserts power to seize drug patents

President Joe Biden speaks about protecting Social Security, Medicare, and lowering prescription drug costs, during a visit to OB Johnson Park and Community Center, in Hallandale Beach, Florida, on Nov. 1, 2022. Kevin Lamarque | Reuters The Biden administration on Thursday opened the door to seizing the patents of certain costly medications from drugmakers in … Read more

Big Pharma takes on counterfeit drugs

Big Pharma takes on counterfeit drugs

In Las Vegas, Lazaro Hernandez was a flamboyant, jet-setting poker player shown in televised tournaments with stacks of colorful chips. But the casually dressed gambler spotted on security cameras with wads of cash at the casino cage was hiding a secret life. And federal investigators say he was gambling with people’s lives. Hernandez, they say, … Read more